Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Oral Health
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Dyslipidemia | Research

Dyslipidemia, diabetes and periodontal disease, a cross-sectional study in Rafsanjan, a region in southeast Iran

Authors: Fatemeh Ayoobi, Somaye Salari Sedigh, Parvin Khalili, Zeinab Sharifi, Hamid Hakimi, Farimah Sardari, Zahra Jamali

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

The objectives

The association between dyslipidemia, diabetes and alterations in periodontal health are inconsistent. The aim of this study was to determine the association between dyslipidemia, diabetes and periodontal disease in the Oral Health Branch of Rafsanjan Cohort Study (OHBRCS).

Methods

Rafsanjan Cohort Study (RCS) was launched in 2015 in Rafsanjan City a region in the southeast of Iran. A total of 8682 participants aged 35–70 years of both gender were recruited into the OHBRCS as a part of RCS. Bleeding on probing (BOP), probing pocket depth (PPD) and Clinical attachment loss (CAL) were used to assess periodontal health status. When CAL progression was ≥ 1 mm and PPD was > 3 mm, it was defined as periodontitis.

Results

The final sample consisted of 6751 individuals with mean age of 47.67 ± 8.79 years. Among this population, 73.32% (n = 4949), 13.75% (n = 928), 59.67% (n = 4028) and 11.76% (n = 794) had BOP, PPD > 3 mm, CAL ≥ 1 mm and periodontitis respectively. The odds of CAL ≥ 1 mm increased 14% in subjects with high LDL cholesterol (OR: 1.14; 95% CI: 1.01–1.30), 17% in subjects with diabetes (OR: 1.17; 95% CI: 1.01–1.36) and 23% in subjects with both dyslipidemia and diabetes (OR: 1.23; 95% CI: 1.05–1.44). Also, the odds of PPD > 3 mm in the group with high total cholesterol (TC) was 16% higher compared to those with normal TC (OR: 1.16; 95% CI: 1.01–1.34).

Conclusions

There was an increased odds in periodontal disease in association with high TC, high LDL cholesterol, diabetes and having both dyslipidemia and diabetes. This suggests that high TC, high LDL cholesterol, diabetes and having both dyslipidemia and diabetes might be potential indicators for the presence of periodontal disease.
Literature
1.
Hujoel PP, Kotsakis G, Hujoel IA. Dental Morbidities, Smoking, oral hygiene, and inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14(12):1840–1.CrossRefPubMed
2.
Papapanou PN, Susin C. Periodontitis epidemiology: is periodontitis under-recognized, over‐diagnosed, or both? Periodontology 2000. 2017;75(1):45–51.
3.
Eke PI, Thornton-Evans G, Dye B, Genco R. Advances in surveillance of periodontitis: the Centers for Disease Control and Prevention periodontal disease surveillance project. J Periodontol. 2012;83(11):1337–42.CrossRefPubMedPubMedCentral
4.
Sculley DV, Langley-Evans SC. Salivary antioxidants and periodontal disease status. Proc Nutr Soc. 2002;61(1):137–43.CrossRefPubMed
5.
Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. The Scientific World Journal. 2020;2020.
6.
Socransky S, Haffajee A, Cugini M, Smith C, Kent R Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–44.CrossRefPubMed
7.
Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. The American Journal of Cardiology and Journal of Periodontology editors’ consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009;80(7):1021–32.CrossRefPubMed
8.
9.
Bascones-Martinez A, Gonzalez-Febles J, Sanz-Esporrin J. Diabetes and periodontal disease. Review of the literature. Am J Dent. 2014;27(2):63–7.PubMed
10.
Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77(8):1289–303.CrossRefPubMed
11.
Almeida Abdo J, Cirano FR, Casati MZ, Ribeiro FV, Giampaoli V, Viana Casarin RC, et al. Influence of dyslipidemia and diabetes mellitus on chronic periodontal disease. J Periodontol. 2013;84(10):1401–8.CrossRefPubMed
12.
Popławska-Kita A, Siewko K, Szpak P, Król B, Telejko B, Klimiuk P et al. Relationship between type 2 diabetes and periodontal disease. Progress in Health Sciences. 2013;3(2).
13.
Ueno M, Takeuchi S, Oshiro A, Shinada K, Ohara S, Kawaguchi Y. Association between diabetes mellitus and oral health status in japanese adults. Int J Oral Sci. 2010;2(2):82–9.CrossRefPubMedPubMedCentral
14.
Darroudi S, Saberi-Karimian M, Tayefi M, Arekhi S, Motamedzadeh Torghabeh A, Seyedzadeh Sani SMR, et al. Prevalence of combined and noncombined dyslipidemia in an iranian population. J Clin Lab Anal. 2018;32(8):e22579.CrossRefPubMedPubMedCentral
15.
Jamali Z, Noroozi Karimabad M, Khalili P, Sadeghi T, Sayadi A, Mohammadakbari Rostamabadi F, et al. Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study. Sci Rep. 2022;12(1):11504.CrossRefPubMedPubMedCentral
16.
Fentoğlu Ö, Öz G, Taşdelen P, Uskun E, Aykaç Y, Bozkurt FY. Periodontal status in subjects with hyperlipidemia. J Periodontol. 2009;80(2):267–73.CrossRefPubMed
17.
Banihashemrad SA, Moeintaghavi A, Rafighdoost A. Relationship between cholesterol and triglyceride blood values and periodontal parameters in patients of Mashhad health center. NY State Dent J. 2008;74(5):65.
18.
Machado ACP, Quirino MRdS, Nascimento LFC. Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Brazilian oral research. 2005;19:284–9.CrossRefPubMed
19.
Sadeghi M, Talaei M, Oveisgharan S, Rabiei K, Dianatkhah M, Bahonar A et al. The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an iranian population: the Isfahan Cohort Study. Adv biomedical Res. 2014;3.
20.
Khamseh ME, Sepanlou SG, Hashemi-Madani N, Joukar F, Mehrparvar AH, Faramarzi E, et al. Nationwide prevalence of diabetes and prediabetes and associated risk factors among iranian adults: analysis of data from PERSIAN cohort study. Diabetes Therapy. 2021;12(11):2921–38.CrossRefPubMedPubMedCentral
21.
Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647–55.CrossRefPubMed
22.
Hakimi H, Ahmadi J, Vakilian A, Jamalizadeh A, Kamyab Z, Mehran M et al. The profile of Rafsanjan Cohort Study. Eur J Epidemiol. 2020:1–10.
23.
Khalili P, Ayoobi F, Mohamadi M, Jamalizadeh A, La Vecchia C, Esmaeili-Nadimi A. Effect of opium consumption on cardiovascular diseases–a cross-sectional study based on data of Rafsanjan cohort study. BMC Cardiovasc Disord. 2021;21(1):1–11.CrossRef
24.
Association AD. Standards of medical care in diabetes—2019 abridged for primary care providers. Clin diabetes: publication Am Diabetes Association. 2019;37(1):11.CrossRef
25.
Kazemi M, Bazyar M, Naghizadeh MM, Dehghan A, Rahimabadi MS, Chijan MR, et al. Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results. Sci Rep. 2021;11(1):1–9.CrossRef
26.
Lang NP, Lindhe J. Clinical periodontology and implant dentistry. 2 ed. Volume Set: John Wiley & Sons; 2015.
27.
Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World workshop on the classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89:173–S82.
28.
Su-Jin Han R, Yi Y-J. The association between dyslipidemia, oral health behavior, and periodontal disease: the Korea National Health and Nutrition Examination Survey. Quintessence Int. 2019;50(5):394–401.PubMed
29.
Schätzle M, Löe H, Bürgin W, Ånerud Ã, Boysen H, Lang NP. Clinical course of chronic periodontitis: I. Role of gingivitis. J Clin Periodontol. 2003;30(10):887–901.CrossRefPubMed
30.
Katz J, Chaushu G, Sharabi Y. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol. 2001;28(9):865–8.CrossRefPubMed
31.
Katz J, Flugelman MY, Goldberg A, Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol. 2002;73(5):494–500.CrossRefPubMed
32.
Morita M, Horiuchi M, Kinoshita Y, Yamamoto T, Watanabe T. Relationship between blood triglyceride levels and periodontal status. Community Dent Health. 2004;21(1):32–6.PubMed
33.
Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol. 2000;27(8):537–41.CrossRefPubMed
34.
Hagh LG, Zakavi F, Hajizadeh F, Saleki M. The association between hyperlipidemia and periodontal infection. Iran Red Crescent Med J. 2014;16(12).
35.
Taleghani F, Shamaei M, Shamaei M. Association between chronic periodontitis and serum lipid levels. 2010.
36.
Penumarthy S, Penmetsa GS, Mannem S. Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients. J Indian Soc periodontology. 2013;17(1):30.CrossRef
37.
Nepomuceno R, Pigossi SC, Finoti LS, Orrico SR, Cirelli JA, Barros SP, et al. Serum lipid levels in patients with periodontal disease: a meta-analysis and meta‐regression. J Clin Periodontol. 2017;44(12):1192–207.CrossRefPubMed
38.
Sayar F, Fallah S, Akhondi N, Jamshidi S. Association of serum lipid indices and statin consumption with periodontal status. Oral Dis. 2016;22(8):775–80.CrossRefPubMed
39.
Fatin Awartani B, Atassi F. Evaluation of periodontal status in subjects with hyperlipidemia. J Contemp Dent Pract. 2010;11(2).
40.
Nazir G, Amin J. Diabetes mellitus and periodontal diseases: a two way relationship. Int J Dentistry Res. 2021;6(2):43–56.CrossRef
41.
Demmer RT, Holtfreter B, Desvarieux M, Jacobs DR Jr, Kerner W, Nauck M, et al. The influence of type 1 and type 2 diabetes on periodontal disease progression: prospective results from the study of Health in Pomerania (SHIP). Diabetes Care. 2012;35(10):2036–42.CrossRefPubMedPubMedCentral
42.
Botero JE, Yepes FL, Roldan N, Castrillón CA, Hincapie JP, Ochoa SP, et al. Tooth and periodontal clinical attachment loss are associated with hyperglycemia in patients with diabetes. J Periodontol. 2012;83(10):1245–50.CrossRefPubMed
43.
Ziukaite L, Slot D, Cobb C, Coucke W, Van der Weijden G. Prevalence of diabetes among patients diagnosed with periodontitis: a retrospective cross-sectional study. Int J Dental Hygiene. 2018;16(2):305–11.CrossRef
44.
Suzuki K, Kurose T, Takizawa M, Maruyama M, Ushikawa K, Kikuyama M, et al. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. Diabetes Res Clin Pract. 2005;68(2):117–25.CrossRefPubMed
45.
Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10(5):497–506.CrossRefPubMedPubMedCentral
46.
Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J oral Microbiol. 2011;3(1):5304.CrossRef
47.
Duarte PM, Szeremeske Miranda T, Lima JA, Dias Gonçalves TE, Santos VR, Bastos MF, et al. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. J Periodontol. 2012;83(4):426–34.CrossRefPubMed
Metadata
Title
Dyslipidemia, diabetes and periodontal disease, a cross-sectional study in Rafsanjan, a region in southeast Iran
Authors
Fatemeh Ayoobi
Somaye Salari Sedigh
Parvin Khalili
Zeinab Sharifi
Hamid Hakimi
Farimah Sardari
Zahra Jamali
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03262-x

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue

Research

Non-invasive diagnostic potential of salivary miR-25-3p for periodontal disease and osteoporosis among a cohort of elderly patients with type 2 diabetes mellitus

Research

Does the “Root Removal First” strategy prevent postoperative complications in the surgical removal of impacted mandibular third molars in the Pell and Gregory class C and horizontal position? — a randomized clinical trial

Research article

Root and canal morphology of mandibular second molars in an Egyptian subpopulation: a cone-beam computed tomography study

Research

Biocompatibility and biofilm formation on conventional and CAD/CAM provisional implant restorations

Research

Evaluating the microbial aerosol generated by dental instruments: addressing new challenges for oral healthcare in the hospital infection

Research

Psychometric evaluation of the Japanese version of the fear of pain questionnaire-III and its association with dental anxiety: a cross-sectional study